| Human mucosal leishmaniasis: neutrophils infiltrate areas of tissue damage that express high levels of Th17‐related cytokines VS Boaventura, CS Santos, CR Cardoso, J de Andrade, WLC Dos Santos, ... European journal of immunology 40 (10), 2830-2836, 2010 | 174 | 2010 |
| CD8+ granzyme B+–mediated tissue injury vs. CD4+ IFNγ+–mediated parasite killing in human cutaneous leishmaniasis C da Silva Santos, V Boaventura, CR Cardoso, N Tavares, MJ Lordelo, ... Journal of Investigative Dermatology 133 (6), 1533-1540, 2013 | 163 | 2013 |
| Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil SV Katikireddi, T Cerqueira-Silva, E Vasileiou, C Robertson, S Amele, ... The Lancet 399 (10319), 25-35, 2022 | 137 | 2022 |
| Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis. CI Brodskyn, A Barral, V Boaventura, E Carvalho, M Barral-Netto Journal of immunology (Baltimore, Md.: 1950) 159 (9), 4467-4473, 1997 | 116 | 1997 |
| Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26. COV2. S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study T Cerqueira-Silva, JR Andrews, VS Boaventura, OT Ranzani, ... The Lancet Infectious Diseases 22 (6), 791-801, 2022 | 113 | 2022 |
| Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil T Cerqueira-Silva, SV Katikireddi, V de Araujo Oliveira, R Flores-Ortiz, ... Nature Medicine 28 (4), 838-843, 2022 | 110 | 2022 |
| Polymerase chain reaction (PCR) is highly sensitive for diagnosis of mucosal leishmaniasis JGS Oliveira, FO Novais, CI De Oliveira, AC da Cruz Junior, LF Campos, ... Acta tropica 94 (1), 55-59, 2005 | 107 | 2005 |
| Arginase I, Polyamine, and Prostaglandin E2 Pathways Suppress the Inflammatory Response and Contribute to Diffuse Cutaneous Leishmaniasis J França-Costa, J Van Weyenbergh, VS Boaventura, NF Luz, ... The Journal of infectious diseases 211 (3), 426-435, 2015 | 92 | 2015 |
| Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study T Cerqueira-Silva, V de Araújo Oliveira, VS Boaventura, JM Pescarini, ... The Lancet Regional Health–Americas 6, 2022 | 76 | 2022 |
| Concomitant early mucosal and cutaneous leishmaniasis in Brazil VS Boaventura, V Cafe, JML Costa, F Oliveira, ALB Bafica, AB Rosato, ... American Society of Tropical Medicine and Hygiene, 2006 | 71 | 2006 |
| Towards a more precise serological diagnosis of human tegumentary leishmaniasis using Leishmania recombinant proteins AP Souza, M Soto, JML Costa, VS Boaventura, CI de Oliveira, JR Cristal, ... PLoS One 8 (6), e66110, 2013 | 66 | 2013 |
| Chemokines and chemokine receptors coordinate the inflammatory immune response in human cutaneous leishmaniasis AP Campanelli, CI Brodskyn, V Boaventura, C Silva, AM Roselino, ... Human Immunology 71 (12), 1220-1227, 2010 | 49 | 2010 |
| Differential Gene Expression and Infection Profiles of Cutaneous and Mucosal Leishmania braziliensis Isolates from the Same Patient EVC Alves-Ferreira, JS Toledo, AHC De Oliveira, TR Ferreira, PC Ruy, ... PLoS Neglected Tropical Diseases 9 (9), e0004018, 2015 | 46 | 2015 |
| Vaccination plus previous infection: protection during the omicron wave in Brazil T Cerqueira-Silva, V de Araujo Oliveira, ES Paixão, PTV Florentino, ... The Lancet Infectious Diseases 22 (7), 945-946, 2022 | 45 | 2022 |
| Systems approach reveals nuclear factor erythroid 2-related factor 2/protein kinase R crosstalk in human cutaneous leishmaniasis ÁC Vivarini, TC Calegari-Silva, AM Saliba, VS Boaventura, ... Frontiers in immunology 8, 1127, 2017 | 43 | 2017 |
| Transient hearing loss in adults associated with Zika virus infection ES Vinhaes, LA Santos, L Dias, NA Andrade, VH Bezerra, ... Clinical Infectious Diseases 64 (5), 675-677, 2017 | 41 | 2017 |
| Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period PTV Florentino, FJO Alves, T Cerqueira-Silva, VA Oliveira, JBS Júnior, ... Nature communications 13 (1), 4756, 2022 | 40 | 2022 |
| Proteome profiling of human cutaneous leishmaniasis lesion C da Silva Santos, S Attarha, RK Saini, V Boaventura, J Costa, R Khouri, ... Journal of Investigative Dermatology 135 (2), 400-410, 2015 | 38 | 2015 |
| Métodos diagnósticos da leishmaniose tegumentar: fatos, falácias e perspectivas BB Andrade, V Boaventura, M Barral-Netto, A Barral Gazeta Médica da Bahia 74 (1), 2008 | 36 | 2008 |
| Surgical treatment of non-embolized patients with nasoangiofibroma AS Fonseca, E Vinhaes, V Boaventura, NA Andrade, LA Dias, V Medeiros, ... Revista Brasileira de Otorrinolaringologia 74, 583-587, 2008 | 36 | 2008 |
Manoel Barral NettoFundação Oswaldo Cruz, FIOCRUZ, BrazilVerified email at fiocruz.br
